Dr. Junxia Min currently serves as a professor at Institute of Translational Medicine & The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou, China. Dr. Min earned her Ph.D. from University of Missouri-Columbia in the United States in 2006. The key finding during her PhD training was discovered the important roles of sphingolipid metabolic pathway in cancer treatment. Since 2010, Dr. Min joined Novartis Department of Oncology as a group leader at Boston, U.S.A., where her group discovered and functionally validated several novel targets for further clinical drug development. Prof. Min's laboratory is mainly focused on 3 areas: 1. to identify novel cancer therapeutics; 2. to design effective interventions for improving health spans for aging populations; and 3. Full optimization for CAR-T.
More event info
- Asian/Pacific Studies Institute